top of page
Strategists and Implementers
for growing companies globally
Recent Postings
Jun 30, 20244 min read
MedNews: Holoclara closes $16 Million financing to advance worm-derived therapies for allergic and autoimmune disease
The company’s discovery engine builds on Dr. Choe’s research uncovering a unique pheromone language shared by roundworms
May 29, 20243 min read
MedNews: MediLink Therapeutics enters into a multi-target technology platform license with the immunotherapy company BioNTech (Nasdaq: BNTX) for therapies for cancer and other serious diseases
MediLink Therapeutics, founded in 2020, is a clinical stage biotech company dedicated to developing conjugated drugs
bottom of page